Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Claudio Cuello

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
Handbook of Clinical Neurology|May 8, 2025
The dependence of basal forebrain cholinergic neurons on NGF: The case in Alzheimer pathologyA Claudio Cuello, Sonia Do Carmo
Frontiers in Neuroscience|February 28, 2019
The Brain NGF Metabolic Pathway in Health and in Alzheimer's PathologyA Claudio Cuello, Rowan Pentz, Hélène Hall
Brain : a Journal of Neurology|March 15, 2022
Reimagining cholinergic therapy for Alzheimer's diseaseEzio Giacobini, A Claudio Cuello, Abraham Fisher
Medecine Sciences : M/S|October 28, 2008
[Paradoxical increase in glutamatergic synaptic terminations in mild cognitive impairment due to Alzheimer's disease]Karen F S Bell, A Claudio Cuello
European Journal of Pharmacology|August 5, 2006
Altered synaptic function in Alzheimer's diseaseKaren F S Bell, A Claudio Cuello
Neuroscience Letters|July 17, 2009
The substance P projections to the frontal cortex and the substantia nigraG Paxinos, P C Emson, A Claudio Cuello
Neuroscience Letters|July 17, 2009
Substance P projections to the entopeduncular nucleus, the medial preoptic area and the lateral septumG Paxinos, P C Emson, A Claudio Cuello
Life Sciences|June 19, 2012
Evidence for the accumulation of Abeta immunoreactive material in the human brain and in transgenic animal modelsA Claudio Cuello, Simon Allard, Maria Teresa Ferretti
Cells|January 11, 2022
The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic AtrophySonia Do Carmo, Benjamin Kannel, A Claudio Cuello
Frontiers in Aging Neuroscience|August 26, 2021
Nerve Growth Factor Compromise in Down SyndromeSonia Do Carmo, Benjamin Kannel, A Claudio Cuello
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Handbook of Clinical Neurology|May 8, 2025
The dependence of basal forebrain cholinergic neurons on NGF: The case in Alzheimer pathologyA Claudio Cuello, Sonia Do Carmo
Frontiers in Neuroscience|February 28, 2019
The Brain NGF Metabolic Pathway in Health and in Alzheimer's PathologyA Claudio Cuello, Rowan Pentz, Hélène Hall
Brain : a Journal of Neurology|March 15, 2022
Reimagining cholinergic therapy for Alzheimer's diseaseEzio Giacobini, A Claudio Cuello, Abraham Fisher
Medecine Sciences : M/S|October 28, 2008
[Paradoxical increase in glutamatergic synaptic terminations in mild cognitive impairment due to Alzheimer's disease]Karen F S Bell, A Claudio Cuello
European Journal of Pharmacology|August 5, 2006
Altered synaptic function in Alzheimer's diseaseKaren F S Bell, A Claudio Cuello
Neuroscience Letters|July 17, 2009
The substance P projections to the frontal cortex and the substantia nigraG Paxinos, P C Emson, A Claudio Cuello
Neuroscience Letters|July 17, 2009
Substance P projections to the entopeduncular nucleus, the medial preoptic area and the lateral septumG Paxinos, P C Emson, A Claudio Cuello
Life Sciences|June 19, 2012
Evidence for the accumulation of Abeta immunoreactive material in the human brain and in transgenic animal modelsA Claudio Cuello, Simon Allard, Maria Teresa Ferretti
Cells|January 11, 2022
The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic AtrophySonia Do Carmo, Benjamin Kannel, A Claudio Cuello
Frontiers in Aging Neuroscience|August 26, 2021
Nerve Growth Factor Compromise in Down SyndromeSonia Do Carmo, Benjamin Kannel, A Claudio Cuello
Pageof 15